ConductScience.org, home

Paper17517847

In vitro interactions between apricitabine and other deoxycytidine analogues.

Bethell R and 6 others. Antimicrob Agents Chemother, 2007. Cited by 17 papers, by iCite.

Cite this record

ConductScience Library. In vitro interactions between apricitabine and other deoxycytidine analogues. Papers, record 17517847. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17517847

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In vitro interactions between apricitabine and other deoxycytidine analogues.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
2007
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
17
iCite
Relative citation ratio, by iCite
0.48
iCite
Revised in PubMed
2018-11-13
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bethell RR
2De Muys JJ
3Lippens JJ
4Richard AA
5Hamelin BB
6Ren CC
7Collins PP

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-HIV AgentsMajor topic
DeoxycytidineMajor topic
HIV-1Major topic
Leukocytes, MononuclearMajor topic
Reverse Transcriptase InhibitorsMajor topic
Drug Interactions
Emtricitabine
HIV Reverse Transcriptase
Humans
Lamivudine
Male
Microbial Sensitivity Tests

Source PubMed

Download CSV of topics

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110882616In vivo antagonism with zidovudine plus stavudine combination therapy.J Infect Dis2000https://conductscience.org/library/papers/10882616PubMed
217242147Effect of Lamivudine on the plasma and intracellular pharmacokinetics of apricitabine, a novel nucleoside reverse transcriptase inhibitor, in healthy volunteers.Antimicrob Agents Chemother2007https://conductscience.org/library/papers/17242147PubMed
312019083Dose range study of pharmacokinetics, safety, and preliminary antiviral activity of emtricitabine in adults with hepatitis B virus infection.Antimicrob Agents Chemother2002https://conductscience.org/library/papers/12019083PubMed
412462795HIV resistance to antiretroviral drugs: mechanisms, genotypic and phenotypic resistance testing in clinical practice.Acta Clin Belg2002https://conductscience.org/library/papers/12462795PubMed
512543687Lamivudine can exert a modest antiviral effect against human immunodeficiency virus type 1 containing the M184V mutation.Antimicrob Agents Chemother2003https://conductscience.org/library/papers/12543687PubMed
612790515Cellular pharmacology of D-d4FC, a nucleoside analogue active against drug-resistant HIV.Antivir Chem Chemother2003https://conductscience.org/library/papers/12790515PubMed
714693537
Equivalent steady-state pharmacokinetics of lamivudine in plasma and lamivudine triphosphate within cells following administration of lamivudine at 300 milligrams once daily and 150 milligrams twice daily.
Antimicrob Agents Chemother2004https://conductscience.org/library/papers/14693537PubMed
815012649Pharmacokinetics of emtricitabine, didanosine and efavirenz administered once-daily for the treatment of HIV-infected adults (pharmacokinetic substudy of the ANRS 091 trial).HIV Med2004https://conductscience.org/library/papers/15012649PubMed
92430286Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.Proc Natl Acad Sci U S A1986https://conductscience.org/library/papers/2430286PubMed
102764535Cellular pharmacology of 2',3'-dideoxy-2',3'-didehydrothymidine, a nucleoside analog active against human immunodeficiency virus.Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2764535PubMed
118175673Divergent anti-human immunodeficiency virus activity and anabolic phosphorylation of 2',3'-dideoxynucleoside analogs in resting and activated human cells.J Biol Chem1994https://conductscience.org/library/papers/8175673PubMed
128769637Intracellular metabolism of zidovudine and stavudine in combination.J Infect Dis1996https://conductscience.org/library/papers/8769637PubMed
139174176Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro.Antimicrob Agents Chemother1997https://conductscience.org/library/papers/9174176PubMed
149337075Lamivudine (3TC) phosphorylation and drug interactions in vitro.Biochem Pharmacol1997https://conductscience.org/library/papers/9337075PubMed
1510428900Anti-human immunodeficiency virus type 1 activity, intracellular metabolism, and pharmacokinetic evaluation of 2'-deoxy-3'-oxa-4'-thiocytidine.Antimicrob Agents Chemother1999https://conductscience.org/library/papers/10428900PubMed
1616092505Intracellular interactions between nucleos(t)ide inhibitors of HIV reverse transcriptase.AIDS Rev2005https://conductscience.org/library/papers/16092505PubMed
1716245645In vitro activity of SPD754, a new deoxycytidine nucleoside reverse transcriptase inhibitor (NRTI), against 215 HIV-1 isolates resistant to other NRTIs.Antivir Chem Chemother2005https://conductscience.org/library/papers/16245645PubMed
1816436719In vitro antiretroviral activity and in vitro toxicity profile of SPD754, a new deoxycytidine nucleoside reverse transcriptase inhibitor for treatment of human immunodeficiency virus infection.Antimicrob Agents Chemother2006https://conductscience.org/library/papers/16436719PubMed
1916816554Efficacy and tolerability of 10-day monotherapy with apricitabine in antiretroviral-naive, HIV-infected patients.AIDS2006https://conductscience.org/library/papers/16816554PubMed
2011227992Correlation between intracellular pharmacological activation of nucleoside analogues and HIV suppression in vitro.Antivir Chem Chemother2000https://conductscience.org/library/papers/11227992PubMed

Download CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.

PMIDTitleJournalYearIn PapersSource
27353267Analysis of the Endogenous Deoxynucleoside Triphosphate Pool in HIV-Positive and -Negative Individuals Receiving Tenofovir-Emtricitabine.Antimicrob Agents Chemother2016https://conductscience.org/library/papers/27353267PubMed
23554824Practical Considerations For Developing Nucleoside Reverse Transcriptase Inhibitors.Drug Discov Today Technol2012https://conductscience.org/library/papers/23554824PubMed
22778958HIV-1 Reverse Transcriptase Still Remains a New Drug Target: Structure, Function, Classical Inhibitors, and New Inhibitors with Innovative Mechanisms of Actions.Mol Biol Int2012https://conductscience.org/library/papers/22778958PubMed
21470681Global gene expression and Ingenuity biological functions analysis on PCBs 153 and 138 induced human PBMC in vitro reveals differential mode(s) of action in developing toxicities.Environ Int2011https://conductscience.org/library/papers/21470681PubMed
21118913Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection.J Antimicrob Chemother2011https://conductscience.org/library/papers/21118913PubMed
17242147Effect of Lamivudine on the plasma and intracellular pharmacokinetics of apricitabine, a novel nucleoside reverse transcriptase inhibitor, in healthy volunteers.Antimicrob Agents Chemother2007https://conductscience.org/library/papers/17242147PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
DCK1633PubTator's text mininghttps://conductscience.org/library/genes/1633

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17517847

GET https://conductscience.org/api/papers/v1/17517847/authors